The impact of histological variants of urothelial carcinoma on clinical outcomes following trimodality bladder-sparing chemoradiation
Over 90% of bladder tumours are urothelial (transitional cell) carcinomas; most of the remainder are pure squamous cell carcinoma (3–5%) and adenocarcinoma (<2%). Invasive urothelial carcinoma (UC) shows diversity in its morphology in pure form, but divergent differentiation is also recognise...
Հիմնական հեղինակներ: | Kiltie, A, Browning, L |
---|---|
Ձևաչափ: | Journal article |
Լեզու: | English |
Հրապարակվել է: |
Elsevier
2017
|
Նմանատիպ նյութեր
-
Radical cystectomy for bladder urothelial carcinoma with aggressive variant histology
: Vahid Mehrnoush, և այլն
Հրապարակվել է: (2022-09-01) -
Induction therapy with ipilimumab and nivolumab followed by consolidative chemoradiation as organ-sparing treatment in urothelial bladder cancer: study protocol of the INDIBLADE trial
: C.F. Stockem, և այլն
Հրապարակվել է: (2023-08-01) -
Variant Histology: The Impact on Oncological Outcomes of Patients with Urothelial Carcinoma of The Bladder Treated with Radical Cystectomy
: Berk Hazır, և այլն
Հրապարակվել է: (2021-12-01) -
Clinical Outcomes of Patients With Variant Histology of Urothelial Carcinoma After Radical Cystectomy
: Dan Bee Lee, և այլն
Հրապարակվել է: (2023-11-01) -
SURVIVAL IN PATIENTS WITH HISTOLOGIC VARIANTS OF UROTHELIAL TYPE BLADDER CANCER
: Richard Hartanto, և այլն
Հրապարակվել է: (2024-09-01)